PENG With LFCB vs. ESP Blocks for Pediatric Hip Surgery

Launched by POZNAN UNIVERSITY OF MEDICAL SCIENCES · Jun 8, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at two different ways to help manage pain for children who are having hip surgery. Specifically, it compares a combination of two types of nerve blocks (the PENG block and LFCB) against another technique that involves blocks in the lower back (L-ESPB and S-ESPB). The goal is to see which method works better for reducing pain after surgery for conditions like hip dysplasia and hip arthropathy.

To participate in this study, children aged 2 to 16 years who are scheduled for certain hip surgeries, like osteotomies or hip reconstructions, may be eligible. Their guardians will need to give written consent for them to join the trial. However, children with certain conditions, like allergies to the medications used in the study, infections at the injection site, or specific neurological disorders, will not be able to participate. If they join, participants can expect close monitoring during their surgery and recovery, helping to ensure that their pain is managed effectively.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Pediatric patients aged between 2 and 16 years.
• • Scheduled for elective orthopedic hip surgery, including: Osteotomies and Hip reconstruction surgeries
• • ASA (American Society of Anesthesiologists) physical status classification: I-III.
• • Written informed consent obtained from the patient's legal guardian(s).
• Exclusion Criteria:
• • Known allergy or hypersensitivity to any of the study medications
• • Presence of infection or inflammation at the intended injection site(s) of regional anesthesia.
• • Coagulopathy or bleeding disorders (including patients on anticoagulant therapy) that contraindicate nerve blocks.
• • Neurological disorders or peripheral neuropathies that could influence sensory or motor assessment of the lower limbs.
• • Cognitive impairment or behavioral disorders significantly affecting pain assessment accuracy or cooperation.
• • History of chronic opioid use or known substance abuse.
• • Severe systemic disease or condition compromising patient safety or interfering with study protocol adherence.